Therefore, T-ALL patients harbouring 5′SE mutations of the TAL1 oncogene represent a specific subgroup with poor prognosis, irrespective of the level of oncogene dysregulation [103]. Here, TAL1 is linked to acute lymphoblastic leukemia.